SEC Form 4 · accession 0001104659-17-074632
Ophthotech Corp. · OPHT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Glenn Sblendorio
Officer — President and CEO · Director
Period of report
Dec 19, 2017
Accepted (ET)
Dec 21, 2017 · 5:08 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001410939
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $2.94 | Dec 19, 2017 | A | 400,000 | A | — | Dec 18, 2027 | Common Stock | 400,000 | 400,000 | D |
Explanation of responses
- F1Subject to continued employment with the Registrant and the other terms and conditions under the Registrant's 2013 Stock Incentive Plan, each of these stock option awards will vest with respect to 25% of the shares subject to the option on the first anniversary of the grant date and with respect to the remaining shares in approximately equal monthly installments through the fourth anniversary of the grant date.